Chief Medical Officer · Whitehawk Therapeutics, Inc. (WHWK)

Loretta Itri

A named executive officer of Whitehawk Therapeutics in every fiscal year CompBrief holds from FY2021 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$1,475,685

Salary $521,475Stock awards $0

FY2022: $1,655,196

5th of 5 named executive officers at Whitehawk Therapeutics by FY2023 total.

5 named officers on file for Whitehawk Therapeutics, FY2023

Loretta Itri’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 2 equity grants, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Whitehawk Therapeutics’s whole pay program stands against its peers

  • Whitehawk Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on WHWK→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 26, 2024 (DEF 14A).

Free

Get Loretta Itri’s full pay file as a PDF — free

More than this page: up to 10 years of Loretta’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Loretta Itri compensation by year

Whitehawk Therapeutics Summary Compensation Table · all 3 fiscal years held
In US dollars, as Whitehawk Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2022FY2023
Salary$96,794$507,620$521,475
Bonus$0$0$0
Stock awards$0$0$0
Option awards$4,967,250$849,346$858,234
Non-equity incentive$0$275,400$44,322
Pension and deferred compensation$0$0$0
All other$0$22,830$51,654
Total$5,064,044$1,655,196$1,475,685

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Whitehawk Therapeutics, Inc. DEF 14A filed April 26, 2024, accession 0001628280-24-018546, and prior-year filings.

How this page was built: the Whitehawk Therapeutics, Inc. filed document, accession 0001628280-24-018546. Every figure is read from that document and cited to the page and table it appears in. Filed April 26, 2024.

$5.1M
$1.7M
$1.5M
FY21
FY22
FY23
SalaryNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
Option102,350—$10.93
Option84,792—$26.85
Option39,259—$17.24

Per the Outstanding Equity Awards at Fiscal Year-End table in Whitehawk Therapeutics, Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Whitehawk Therapeutics’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Neil DesaiExecutive Chairman$2,162,314
David LennonPresident and Chief Executive Officer$2,135,688
Scott GiacobelloChief Financial Officer and Former Interim President and Chief Executive Officer$1,971,183
Brendan DelaneyFormer President and Chief Executive Officer$1,645,015
Loretta Itri · this pageChief Medical Officer$1,475,685

The full Whitehawk Therapeutics compensation record

free company brief

This page is one person within Whitehawk Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Whitehawk Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Loretta Itri's compensation dossier · One-time report. No refunds.